Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Micronized Progesterone for Prevention of Spontaneous Preterm Birth
NCT02571296Phase 4Unknown
- Sponsor
- Ghamra Military Hospital
- Start
- Jul 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in preterm birth comparing Micronized Progesterone with Placebo (2 arms). Primary endpoint: Rate of preterm delivery (<37 weeks). Status: unknown.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT02571296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571296.